Trial Outcomes & Findings for Effect of Cyclic Loading (Vibration) on Orthodontic Tooth Movement (NCT NCT00830947)
NCT ID: NCT00830947
Last Updated: 2013-12-23
Results Overview
Recruitment status
COMPLETED
Study phase
PHASE3
Target enrollment
45 participants
Primary outcome timeframe
Time to Space Closure, an average of 22 weeks
Results posted on
2013-12-23
Participant Flow
Participant milestones
| Measure |
OrthoAccel Device
OrthoAccel Device : The OA device provides a light vibration at 0.2 Newtons and 30 Hz. frequency for 20 minutes daily.
|
Sham (Inactive Device)
Sham Device : Inactive sham device that is held in the mouth for 20 minutes.
|
|---|---|---|
|
Overall Study
STARTED
|
23
|
22
|
|
Overall Study
COMPLETED
|
19
|
18
|
|
Overall Study
NOT COMPLETED
|
4
|
4
|
Reasons for withdrawal
| Measure |
OrthoAccel Device
OrthoAccel Device : The OA device provides a light vibration at 0.2 Newtons and 30 Hz. frequency for 20 minutes daily.
|
Sham (Inactive Device)
Sham Device : Inactive sham device that is held in the mouth for 20 minutes.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
4
|
4
|
Baseline Characteristics
Effect of Cyclic Loading (Vibration) on Orthodontic Tooth Movement
Baseline characteristics by cohort
| Measure |
OrthoAccel Device
n=23 Participants
OrthoAccel Device : The OA device provides a light vibration at 0.2 Newtons and 30 Hz. frequency for 20 minutes daily.
|
Sham (Inactive Device)
n=22 Participants
Sham Device : Inactive sham device that is held in the mouth for 20 minutes.
|
Total
n=45 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age Continuous
|
21.8 years
STANDARD_DEVIATION 8.7 • n=5 Participants
|
21.4 years
STANDARD_DEVIATION 7.8 • n=7 Participants
|
21.6 years
STANDARD_DEVIATION 8.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Time to Space Closure, an average of 22 weeksOutcome measures
| Measure |
OrthoAccel Device
n=23 Participants
OrthoAccel Device : The OA device provides a light vibration at 0.2 Newtons and 30 Hz. frequency for 20 minutes daily.
|
Sham (Inactive Device)
n=22 Participants
Sham Device : Inactive sham device that is held in the mouth for 20 minutes.
|
|---|---|---|
|
The Rate of Orthodontic Movement of a Maxillary Canine Tooth Being Distalized to Close an Extraction Space.
|
0.27 mm/week
Standard Deviation 0.04
|
0.18 mm/week
Standard Deviation 0.04
|
Adverse Events
OrthoAccel Device
Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths
Sham (Inactive Device)
Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
OrthoAccel Device
n=23 participants at risk
OrthoAccel Device : The OA device provides a light vibration at 0.2 Newtons and 30 Hz. frequency for 20 minutes daily.
|
Sham (Inactive Device)
n=22 participants at risk
Sham Device : Inactive sham device that is held in the mouth for 20 minutes.
|
|---|---|---|
|
Gastrointestinal disorders
Hypoaestesia oral
|
0.00%
0/23
|
4.5%
1/22
|
|
Gastrointestinal disorders
Nausea
|
4.3%
1/23
|
0.00%
0/22
|
|
Gastrointestinal disorders
Retching
|
0.00%
0/23
|
4.5%
1/22
|
|
Gastrointestinal disorders
Toothache
|
8.7%
2/23
|
0.00%
0/22
|
|
General disorders
Malaise
|
4.3%
1/23
|
0.00%
0/22
|
|
General disorders
Sensation of pressure
|
4.3%
1/23
|
0.00%
0/22
|
|
Injury, poisoning and procedural complications
Medical device discomfort
|
0.00%
0/23
|
4.5%
1/22
|
|
Injury, poisoning and procedural complications
Medical device pain
|
8.7%
2/23
|
4.5%
1/22
|
|
Injury, poisoning and procedural complications
TAD Failure
|
4.3%
1/23
|
4.5%
1/22
|
|
Musculoskeletal and connective tissue disorders
Pain in jaw
|
0.00%
0/23
|
4.5%
1/22
|
|
Nervous system disorders
Headache
|
4.3%
1/23
|
9.1%
2/22
|
|
Nervous system disorders
Hypoaesthesia
|
4.3%
1/23
|
0.00%
0/22
|
|
Respiratory, thoracic and mediastinal disorders
Sneezing
|
4.3%
1/23
|
0.00%
0/22
|
Additional Information
Zaffer Syed, Director of Clinical & Regulatory Affairs
OrthoAccel Technologies, Inc.
Phone: (832) 803-0339
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60